Evidence map›Paper›PMID 40555685›Full record

ArticleDiabetes, obesity & metabolism2025

Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand.

Sara Mustafa, Christopher Mayo, Ryan Paul, Mark Rodrigues, Rinki Murphy, Rawiri Keenan, Lynne Chepulis

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara MustafaDivision of Health, University of Waikato, Hamilton, Waikato, New Zealand.ORCID https://orcid.org/0000-0001-5902-5622
Christopher MayoTe Whatu Ora Health New Zealand, Hamilton, Waikato, New Zealand.
Ryan PaulDivision of Health, University of Waikato, Hamilton, Waikato, New Zealand.
Mark RodriguesDivision of Health, University of Waikato, Hamilton, Waikato, New Zealand.
Rinki MurphyTe Whatu Ora Health New Zealand, Hamilton, Waikato, New Zealand.ORCID https://orcid.org/0000-0002-0043-2423
Rawiri KeenanDivision of Health, University of Waikato, Hamilton, Waikato, New Zealand.
Lynne ChepulisDivision of Health, University of Waikato, Hamilton, Waikato, New Zealand.

Funding

Health Research Council of New Zealand 21/839
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dulaglutideempagliflozinmedication adherenceNew Zealandprimary caretype 2 diabetes

Identifiers

PMID40555685
PMCPMC12326907

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.